Showing results (1311-1320 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|April 27, 2026
A randomized controlled trial of L-taurine for fatigue in decompensated cirrhosisSwarup Sasidharan, Cyriac Abby Philips, Ajit Tharakan, et al.
Hepatology Communications|April 20, 2026
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinomaKelley Núñez, Navid Hasani, Julie Cronan, et al.
Hepatology Communications|November 18, 2021
Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable PopulationsRebecca G Kim, Sheyla P Medina, Catherine Magee, et al.
Hepatology Communications|June 19, 2026
The PERK-GADD45A axis is a key driver of hepatic stellate cell activationNipuni Barupala, Jagannath Misra, Emely Bibian, et al.
Hepatology Communications|June 19, 2026
Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populationsNeehar D Parikh, Chun-Chi Liu, Matthew DeMaio, et al.
Hepatology Communications|May 26, 2026
Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapySatoshi Shigeno, Takahiro Kodama, Kazuhiro Murai, et al.
Hepatology Communications|June 11, 2026
Depletion of NAT10 in T cells attenuates metabolic dysfunction-associated steatohepatitis in miceYanying Yang, Jie Lu, Mingyue Ma, et al.
Hepatology Communications|June 11, 2026
Gut microbiota-derived indole-3-propionic acid alleviates endoplasmic reticulum stress by regulating FMO2 in MASLDYue Luo, Yuefeng Zhang, Qian Zhang, et al.
Hepatology Communications|July 22, 2026
Efficacy, safety, and pharmacokinetics of rifaximin in pediatric patients with hepatic encephalopathy in Japan: An open-label studyHideaki Okajima, Masashi Tagawa, Masaki Fujisawa, et al.
Pageof 179